Why does Sunosi (solriamfetol) cost so much?
Sunosi’s price is largely driven by how it is marketed and reimbursed in the U.S., plus the economics of developing and supplying a branded prescription medicine. As a newer, specialty-branded product, it typically has higher list prices than older, off-patent generics, and the cost can be amplified by pharmacy benefit design (for example, tier placement) and manufacturer pricing strategy.
What makes prior authorization common for Sunosi?
Prior authorization (PA) is often required because insurers want to confirm that Sunosi is being used for an FDA-approved indication and that other, lower-cost options aren’t more appropriate for a member. For drugs like Sunosi—used for specific sleep-related conditions—insurers commonly request documentation such as:
- the diagnosis and symptoms
- whether the patient has tried or is using recommended non-drug approaches
- baseline measures of sleepiness/functioning and the expected target benefit
- medication history and safety considerations
This control helps payers manage utilization and avoid coverage for off-label or low-value use.
How does the PA process affect your out-of-pocket cost?
If PA isn’t approved, coverage can be denied or restricted, which can push patients toward the cash price (often much higher). Even when coverage is eventually approved, step edits (trying other treatments first) and formulary tiers can still affect copays and coinsurance.
When are insurers most likely to approve Sunosi?
Approvals are more likely when the prescription aligns with the insurer’s coverage criteria for the specific approved use (for example, documented excessive daytime sleepiness associated with a qualifying condition) and when the prescriber provides the requested clinical details. Strong documentation reduces back-and-forth and the chance of an automatic denial.
Are there cheaper alternatives if Sunosi is too expensive?
The main cost-lowering routes are usually:
- checking formulary alternatives within the same coverage tier (if the plan has them)
- moving to an insurer-approved brand or preferred drug option for excessive sleepiness, when clinically appropriate
- using manufacturer savings programs or patient assistance (if eligible)
- switching pharmacies to find a lower negotiated price
- requesting a PA appeal if the initial request was denied
If you share your diagnosis and your insurance plan type (commercial, Medicare, Medicaid) I can outline what to ask your doctor and what to request during PA.
What to do if your PA is denied
Common next steps include asking for the denial reason and submitting a targeted resubmission with missing documentation (diagnosis, supporting symptoms, prior therapy history, and prescriber rationale). If you believe the drug is medically necessary, an appeal can change the outcome.
Sources
I don’t have the specific pricing and insurer criteria details for Sunosi in the information provided here, so I can’t cite exact figures or a specific PA policy. If you paste your plan’s PA requirements or the denial letter text, I can help you interpret it and draft what to send back to the insurer.